Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sun Yat-sen University
University of Michigan Rogel Cancer Center
George Washington University
Groupe Oncologie Radiotherapie Tete et Cou
University of Chicago
University of Michigan Rogel Cancer Center
University of Arizona
University of Leipzig
Rabin Medical Center